Inflammation-targeting drug misses mark in heart disease study4 hours agoclinical trial failureNovo Nordiskziltivekimabhttps://www.statnews.com/2026/07/31/novo-nordisk-inflammation-heart-disease-ziltivekimab/Copy Link